North South Ventures

North South Ventures is a cross-border venture capital fund that focuses on early-stage medical companies. The firm is strategically co-located in academic medical superclusters such as Stanford/UCSF and the University of Toronto, giving it access to proprietary deal flow from top US and Canadian academic centers. North South Ventures typically invests in seed and Series A rounds, supporting companies in the biotech, medical device, and digital health/AI sectors.

The firm's notable portfolio companies include Droplet Biosciences, Persephone Biosciences, and YourChoice Therapeutics. North South Ventures has a robust track record with over 350 medical portfolio companies and more than 40 FDA approvals, contributing to $10 billion in cumulative funding and multiple billion-dollar IPOs. The firm emphasizes a "people first, companies second" investment philosophy and offers unique value-add services through its deep connections in academic and medical research communities.